CD226 and ovarian cancer: Collectively, these data indicate that in PB- and MA-derived macrophages from high-grade ovarian cancer patients the increased frequency of TIGIT, CD226, TIM-3, and LAG-3 positive cells is associated with an M2 phenotype.